Payers and manufacturers of curative therapies are beginning to contemplate ways to mitigate, share, or distribute the risks and costs associated with these therapies. This report evaluates seven potential payment models that could be instituted in the real world, using various illustrative scenarios.

This article was first published by the Society of Actuaries.